It's here! The new “CRN Connect” mobile app is now available to help you stay up-to-date on CRN news and engaged in your committees—a top tip for making the most of your membership. Developed to provide an easy way to keep track of committee meetings, resources, and CRN/industry events, the app also features a newsfeed with filtered committee updates, member-to-member messaging, and discussion forums.
CRN Daily Supplement
Participating in CRN committees and working groups is a primary way for you, as a CRN member, to shape the dietary supplement industry. Active participation contributes to your company's success by allowing you to be "surrounded by other people who are faced with the same challenges you are and are as committed as you are to providing solutions, to driving the narrative and not just sitting on the sidelines," Scott Ravech, CEO of Deerland Probiotics & Enzymes, as well as a CRN officer and board member, Membership Committee member and new member mentor advises.
CRN’s Andrea Wong, Ph.D., senior vice president, scientific & regulatory affairs made clear to consumers the value of multivitamins in a widely-quoted response to Monday's British Medical Journal study calling into question the real benefits of taking these products. Plus, get ready for CRN's new mobile app—coming in December.
Companies that need capital in these times, but face senior lenders either too busy or too risk-averse in this environment, can find financing via non-bank options and avoid issuing equity at potentially lower valuations.
Join us October 13–16 for CRN’s annual industry-wide events for dietary supplement professionals, presented online in 2020 to keep you safe and expand our reach. Following SCIENCE In Session—two half-days of deeper dives into timely scientific topics taking place Oct. 13–14—CRN will present NOW, NEW, NEXT Oct. 14–16, with updates on the association's initiatives including its annual Consumer Survey, as well as an address from FDA leadership.
CRN and its members should recognize that the credibility of individual companies and of the dietary supplement and functional food industry as a whole depends upon fairness in the marketplace, with respect to individual consumers, the public at large, government agencies, state and federal legislatures, the professional and academic communities, and fellow members of the industry and its supporting suppliers.
The fundamental importance of ensuring studies are well-designed has been magnified by challenges brought about by COVID-19. The pandemic has also shown that attentive, engaged, and communicative partnerships among research organizations and their sponsors is critical.
Managing the overages of the dietary ingredient(s) in vitamins, minerals and dietary supplements can be among the most technically challenging Good Manufacturing Practices (GMP) problems that vitamin, mineral and supplement formulators and manufacturers must address. Moreover, as failure to adequately manage overages can lead to excessive production costs, stability concerns, and even regulatory and safety risks, it is in the interest of the manufacturer and the consumer that the formulator invest the time and effort to do this wisely. In some cases, hiring a technically proficient consultant well versed in dietary supplement GMPs is the most efficient method of doing so.
This year, The Workshop: CRN’s Day of Science is transforming to span two half-days, renamed as Science In Session, and The Conference: CRN’s Annual Symposium for the Dietary Supplement Industry, CRN’s traditional in person meeting, will be reimagined as a virtual experience with the theme, Now, New, Next.
CRN and its members recognize the important role of laws and regulations, and the state and federal agencies that implement them, to assure that the best interests of the public are promoted and protected. Although CRN may on occasion advocate for changes in those laws that are inconsistent with the best interests of the public and the industry, CRN members should adhere to all relevant laws and regulations while they are in place.